Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
239.00
+17.20 (7.75%)
At close: Apr 29, 2026
HKG:2637 Market Cap
HKG:2637 has a market cap or net worth of 18.81 billion as of April 29, 2026.
Market Cap
18.81B
Enterprise Value
17.45B
Revenue
648.05M
Ranking
n/a
PE Ratio
84.33
Stock Price
239.00
Market Cap Chart
Since October 20, 2025, HKG:2637's market cap has increased from 8.20B to 18.81B, an increase of 129.37%. That is a compound annual growth rate of 392.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 17.46B | 63.09% |
| Dec 31, 2025 | 10.70B | 30.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| The United Laboratories International Holdings | 18.94B |
| Grand Pharmaceutical Group | 22.20B |
| Consun Pharmaceutical Group | 13.56B |
| CanSino Biologics | 12.90B |
| Sunshine Lake Pharma | 23.80B |
| Xuanzhu Biopharmaceutical | 12.59B |
| Sihuan Pharmaceutical Holdings Group | 11.84B |
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |